Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
about
Teriflunomide for multiple sclerosisPonesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseasesTeriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.Teriflunomide: a review of its use in relapsing multiple sclerosis.Teriflunomide: a novel oral treatment for relapsing multiple sclerosis.Teriflunomide for the treatment of relapsing-remitting multiple sclerosis.Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis.Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations.Teriflunomide for multiple sclerosis in real-world setting.Teriflunomide in multiple sclerosis: an update.Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosis.
P2860
Q24186016-9E051CC7-320B-4DFD-9FBD-6CABFDF1B63DQ26771821-182459A2-AF4E-47D1-825E-C5084A2CBDA5Q34136472-F54898F6-F327-4138-B73C-98BC667DBC0EQ34389332-9CA5DAFD-8F9E-4438-9888-3F2F7C3EC9F9Q38160410-BA6DA6A6-D253-47BB-8CAA-0331B2F1CA7BQ38205268-2B9BC974-72B1-47F9-BDC8-754A4B7386ABQ38289353-1F4F4D3C-6E7B-4E21-8F69-E08E8E1830AEQ38375671-2E07BA20-1206-4C15-A0A2-A39AFC1536CEQ38735869-9E41DDE1-09F3-49CA-B71F-46487D2CD4E4Q38891855-948591BE-BF0A-4EEF-B35F-D834543B9FBAQ39114065-B5CBEA78-15EC-492D-90A2-8B39C373876BQ40090879-14801D4A-9626-44D2-9434-271808E3374A
P2860
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Teriflunomide reduces relapse- ...... pitalizations and steroid use.
@en
Teriflunomide reduces relapse- ...... pitalizations and steroid use.
@nl
type
label
Teriflunomide reduces relapse- ...... pitalizations and steroid use.
@en
Teriflunomide reduces relapse- ...... pitalizations and steroid use.
@nl
prefLabel
Teriflunomide reduces relapse- ...... pitalizations and steroid use.
@en
Teriflunomide reduces relapse- ...... pitalizations and steroid use.
@nl
P2093
P2860
P1433
P1476
Teriflunomide reduces relapse- ...... pitalizations and steroid use.
@en
P2093
Aaron E Miller
Catherine Dive-Pouletty
Christian Confavreux
Fred D Lublin
Gaëlle Bégo-Le-Bagousse
Jerry S Wolinsky
Mark S Freedman
Paul W O'Connor
Tomas P Olsson
P2860
P2888
P304
P356
10.1007/S00415-013-6979-Y
P577
2013-07-14T00:00:00Z